40 related articles for article (PubMed ID: 38646431)
1. A case of left atrial intimal sarcoma with rhabdomyosarcoma differentiation: a case report and literature review.
Shu H; Xiao D; Han S; Du Y; Lin J; Li Q
Front Oncol; 2024; 14():1340115. PubMed ID: 38835391
[TBL] [Abstract][Full Text] [Related]
2. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
Giner F; Machado I; Rubio-Martínez LA; López-Guerrero JA; Claramunt-Alonso R; Navarro S; Ferrández A; Mayordomo-Aranda E; Llombart-Bosch A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108696
[TBL] [Abstract][Full Text] [Related]
3. Primary sarcoma of the heart: case report and literature review.
Moeri-Schimmel R; Pras E; Desar I; Krol S; Braam P
J Cardiothorac Surg; 2020 May; 15(1):104. PubMed ID: 32430055
[TBL] [Abstract][Full Text] [Related]
4. Case report: Navigating treatment pathways for cardiac intimal sarcoma with
Nishiyama A; Sato S; Sakaguchi H; Kotani H; Yamashita K; Ohtsubo K; Mizuguchi K; Ikeda H; Iino K; Takemura H; Takeuchi S
Front Oncol; 2024; 14():1362347. PubMed ID: 38646431
[TBL] [Abstract][Full Text] [Related]
5. Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing.
Ito Y; Maeda D; Yoshida M; Yoshida A; Kudo-Asabe Y; Nanjyo H; Izumi C; Yamamoto F; Inoue M; Shibata H; Katoh H; Ishikawa S; Nakamura H; Totoki Y; Shibata T; Yachida S; Goto A
Virchows Arch; 2017 Sep; 471(3):423-428. PubMed ID: 28474091
[No Abstract] [Full Text] [Related]
6. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature.
Koelsche C; Benhamida JK; Kommoss FKF; Stichel D; Jones DTW; Pfister SM; Heilig CE; Fröhling S; Stenzinger A; Buslei R; Mentzel T; Baumhoer D; Ladanyi M; Antonescu CR; Flucke U; Gorp JV; Bode-Lesniewska B; Deimling AV; Mechtersheimer G
Mod Pathol; 2021 Dec; 34(12):2122-2129. PubMed ID: 34312479
[TBL] [Abstract][Full Text] [Related]
7. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
[TBL] [Abstract][Full Text] [Related]
8. Primary cardiac sarcomas: A clinicopathologic study in a single institution with 25 years of experience with an emphasis on MDM2 expression and adjuvant therapy for prognosis.
Cho H; Song IH; Jo U; Jeong JS; Koo HJ; Yang DH; Jung SH; Song JS; Cho KJ
Cancer Med; 2023 Aug; 12(16):16815-16828. PubMed ID: 37395142
[TBL] [Abstract][Full Text] [Related]
9. Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study.
Koyama T; Shimizu T; Kojima Y; Sudo K; Okuma HS; Shimoi T; Ichikawa H; Kohsaka S; Sadachi R; Hirakawa A; Yoshida A; Ando RM; Ueno T; Yanagaki M; Matsui N; Nakamura K; Yamamoto N; Yonemori K
Cancer Discov; 2023 Aug; 13(8):1814-1825. PubMed ID: 37369013
[TBL] [Abstract][Full Text] [Related]
10. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Fennell DA; King A; Mohammed S; Greystoke A; Anthony S; Poile C; Nusrat N; Scotland M; Bhundia V; Branson A; Brookes C; Darlison L; Dawson AG; Gaba A; Hutka M; Morgan B; Bajaj A; Richards C; Wells-Jordan P; Thomas A;
Lancet Oncol; 2022 Mar; 23(3):374-381. PubMed ID: 35157829
[TBL] [Abstract][Full Text] [Related]
11. Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report.
Sai S; Imamura Y; Kiyota N; Jimbo N; Toyoda M; Funakoshi Y; Chayahara N; Hyogo Y; Takenaka K; Suto H; Minami H
Mol Clin Oncol; 2021 Jan; 14(1):6. PubMed ID: 33262886
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Frezza AM; Assi T; Lo Vullo S; Ben-Ami E; Dufresne A; Yonemori K; Noguchi E; Siontis B; Ferraro R; Teterycz P; Duffaud F; Ravi V; Vincenzi B; Gelderblom H; Pantaleo MA; Baldi GG; Desar I; Fedenko A; Maki RG; Jones RL; Benjamin RS; Blay JY; Kawai A; Gounder M; Gronchi A; Le Cesne A; Mir O; Czarnecka AM; Schuetze S; Wagner AJ; Adam J; Barisella M; Sbaraglia M; Hornick JL; Meurgey A; Mariani L; Casali PG; Thornton K; Stacchiotti S
Cancer; 2020 Jan; 126(1):98-104. PubMed ID: 31536651
[TBL] [Abstract][Full Text] [Related]
13. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.
Roszik J; Khan A; Conley AP; Livingston JA; Groisberg R; Ravi V; Carmagnani Pestana R; Sen S; Subbiah V
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480474
[TBL] [Abstract][Full Text] [Related]
14. Activating mutation of
Fu X; Niu W; Li J; Kiliti AJ; Al-Ahmadie HA; Iyer G; Gao SP; Li Q
Oncotarget; 2017 Oct; 8(46):81709-81716. PubMed ID: 29113426
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
